247 related articles for article (PubMed ID: 17236969)
21. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation.
Yilmaz YF; Aytas FI; Akdogan O; Sari K; Savas ZG; Titiz A; Tumoz M; Unal A
Otol Neurotol; 2008 Jun; 29(4):461-3. PubMed ID: 18520582
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
23. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
24. Moist skin care can diminish acute radiation-induced skin toxicity.
Momm F; Weissenberger C; Bartelt S; Henke M
Strahlenther Onkol; 2003 Oct; 179(10):708-12. PubMed ID: 14566480
[TBL] [Abstract][Full Text] [Related]
25. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
27. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
Miller MW; Riedel G; Hoistad D; Sutherland C; Juhn SK; Adams GL; Griffin R; Ondrey FG
Am J Otolaryngol; 2009; 30(1):1-7. PubMed ID: 19027506
[TBL] [Abstract][Full Text] [Related]
28. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
29. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.
Ruben JD; Dally M; Bailey M; Smith R; McLean CA; Fedele P
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):499-508. PubMed ID: 16517093
[TBL] [Abstract][Full Text] [Related]
30. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
33. Radiation dose to otologic structures during head and neck cancer radiation therapy.
Ondrey FG; Greig JR; Herscher L
Laryngoscope; 2000 Feb; 110(2 Pt 1):217-21. PubMed ID: 10680919
[TBL] [Abstract][Full Text] [Related]
34. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
[TBL] [Abstract][Full Text] [Related]
35. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
36. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
Villar A; Martinez JC; de Serdio JL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
[TBL] [Abstract][Full Text] [Related]
37. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
38. Thyroid dysfunction in patients treated with radiotherapy for neck.
Koc M; Capoglu I
Am J Clin Oncol; 2009 Apr; 32(2):150-3. PubMed ID: 19307948
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
40. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
